Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

অনুরূপ উপাদানগুলি

• Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
  অনুযায়ী: Hata N, অন্যান্য
  প্রকাশিত: (2016-11-01)
• Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
  অনুযায়ী: Cairncross, J. Gregory, অন্যান্য
  প্রকাশিত: (2014)
• Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
  অনুযায়ী: Hata, Nobuhiro, অন্যান্য
  প্রকাশিত: (2017)
• AT-56 TREATMENT OF LARGE LOW-GRADE OLIGODENDROGLIAL TUMORS WITH UPFRONT PROCARBAZINE, LOMUSTINE, AND VINCRISTINE CHEMOTHERAPY WITH LONG FOLLOW-UP: A RETROSPECTIVE COHORT STUDY WITH GROWTH KINETICS
  অনুযায়ী: Taal, Walter, অন্যান্য
  প্রকাশিত: (2014)
• Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri
  অনুযায়ী: Lee, Hyun Gon, অন্যান্য
  প্রকাশিত: (2014)